» Articles » PMID: 23390885

Physicians' Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice Within a Major Healthcare System

Overview
Date 2013 Feb 9
PMID 23390885
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Physicians will play a large role in the delivery of genomic medicine, given the limited number of trained genetics professionals. The objective of this study was to assess physician preparedness for incorporating genomic testing (GT) and pharmacogenetic testing (PT) into practice by determining knowledge, experience, comfort level, and barriers, as well as their expectations for practice and educational needs.

Methods: A 30-question survey was distributed to physicians spanning all disciplines within our healthcare system.

Results: Perceived knowledge was poor; 40%-72% reported "no to minimal knowledge" for all genomics topics. Recent graduates or those with no patients who had undergone GT or PT had lower comfort levels. Participating physicians anticipate usage to increase; however, most were uncertain when and how to incorporate genomics into practice. Physicians perceived lack of knowledge and time to keep updated as their greatest barriers to incorporating GT and PT into practice.

Conclusion: Overall, physicians appear underprepared, perceiving they lack sufficient knowledge and confidence to incorporate GT and PT into practice. The majority of physicians expect their role in GT and PT to increase. The results underscore the importance of enhancing policies and initiatives to increase physician knowledge and comfort level.

Citing Articles

Clinical implementation of preemptive pharmacogenomics testing for personalized medicine at an academic medical center.

Tamraz B, Shin J, Khanna R, Van Ziffle J, Knowles S, Stregowski S J Am Med Inform Assoc. 2024; 32(3):566-571.

PMID: 39665424 PMC: 11833476. DOI: 10.1093/jamia/ocae293.


Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma.

Hollitt G, Keane M, Nguyen T, Hassall M, Siggs O, Craig J Clin Exp Ophthalmol. 2024; 52(9):957-972.

PMID: 39245560 PMC: 11620848. DOI: 10.1111/ceo.14438.


Implementing HLA-B*58:01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors' and patients' perspective.

Ng W, Hussein N, Jenn Ng C, Qureshi N, Lee Y, Kwan Z PLoS One. 2024; 19(1):e0296498.

PMID: 38206925 PMC: 10783771. DOI: 10.1371/journal.pone.0296498.


Personalized medicine in a community health system: the NorthShore experience.

David S, Dunnenberger H, Choi S, DePersia A, Ilbawi N, Ward C Front Genet. 2023; 14:1308738.

PMID: 38090148 PMC: 10713750. DOI: 10.3389/fgene.2023.1308738.


Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening.

Lapointe J, Cote J, Mbuya-Bienge C, Dorval M, Pashayan N, Chiquette J J Pers Med. 2023; 13(7).

PMID: 37511640 PMC: 10381377. DOI: 10.3390/jpm13071027.